First experience in Switzerland in Phe508del homozygous cystic fibrosis patients with end-stage pulmonary disease enrolled in a lumacaftor-ivacaftor therapy trial – preliminary results. (2018). Swiss Medical Weekly, 148(0708), w14593. https://doi.org/10.4414/smw.2018.14593